Hydrochlorothiazide/Metoprolol Tartrate

氢氯噻嗪/酒石酸美托洛尔

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrochlorothiazide/Metoprolol Tartrate
Drug Alias Name氢氯噻嗪酒石酸美托洛尔Hydrochlorothiazide/Metoprolol酒石酸美托洛尔氢氯噻嗪Metoprolol Tartrate and Hydrochlorothiazide酒石酸美托洛尔和氢氯噻嗪 +[10] 
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterBeta adrenergic receptors
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1984/12/31
Country/TerritoryUnited States
CombinationsYes HydrochlorothiazideMetoprolol Tartrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesValidus Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC03AX01C07BB52
Related LinksN/A